Browse News
Filter News
Found 572,346 articles
-
The digital-enabled aspect of the manufacturing plant is designed to leverage better use of data to optimize manufacturing processes and increase efficiencies.
-
Top Science Mishaps Over the Past 10 Years
10/15/2019
Lab accidents are listed by date, from most recent to earliest, along with the name of the lab, the location and a summary of the incident. -
Reata announced late Monday that the second part of its Phase II MOXIe trial met the goal of modified Friedreich’s Ataxia Rating Scale after 48 weeks of treatment.
-
Harborside Inc. Announces Extension of Voluntary Lock-Up Agreements with Key Executives, Board Members and Insiders
10/15/2019
Harborside Inc. ("Harborside" or the "Company") (CSE: HBOR), a California-focused, vertically integrated cannabis enterprise, announced today that key executives, members of the Board of Directors and insiders, have entered into an additional, extended voluntary lock-up agreement with the Company,
-
Ortho Clinical Diagnostics to Demonstrate How Data Management Can Empower Labs During AABB Annual Meeting and Special Customer Event at Historic Sunset Station
10/15/2019
In Addition, Ortho to Celebrate 1,000 ORTHO VISION® Analyzers Installed in US Labs
-
Fluxtrol Inc. Taps Producer Stephen Sadler, Author Josef Bastian, Marvel Artist Patrick McEvoy, to Develop New Educational Comic Book Superhero Series, The Adventures of Fluxtrol Man
10/15/2019
In late 2018, Robert Ruffini, President of Fluxtrol Inc., and Producer / Writer / Digital Strategist, Stephen Sadler, started discussing a project with a simple goal in mind - to create a unique way to tell Fluxtrol’s story.
-
CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology
10/15/2019
KSQ Therapeutics to receive non-exclusive access to certain CRISPR IP for its autologous cell therapies, including its existing eTIL™ cell franchise
-
IRRAS to Present at the 17th Neurocritical Care Society's Annual Meeting
10/15/2019
Company is co-hosting a Breakfast Symposium with the Neurocritical Care Society
-
Abacus Health Products Enters U.S. Convenience Store Market With New Distribution Agreement
10/15/2019
Abacus Health Products, Inc. (CSE: ABCS, OTCQX: ABAHF) (“Abacus” or the “Company”) today announced that it would be entering the convenience store market segment through an agreement with E&S International Enterprises, Inc. (“ESI”), for the distribution of CBDMEDIC™ products to this channel.
-
Assure Neuromonitoring Earns Joint Commission AccreditationMarket Leader Receives Prestigious Surgical Ambulatory Healthcare Accreditation
10/15/2019
Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced that it has earned The Joint Commission’s Surgical Ambulatory Health Care Accreditation by demonstrating continuous compliance with its performance standards.
-
Nabriva to Present Data at the CHEST Annual Meeting Demonstrating the Safety and Efficacy of Newly FDA-Approved XENLETA (lefamulin) for the Treatment of CABP Poster sessions to highlight pooled results from the pivo
10/15/2019
Nabriva Therapeutics plc announced that it will present data on the pooled results from completed Phase 3 trials of XENLETA™ at the CHEST Annual Meeting 2019, to be held October 19-23 in New Orleans.
-
Spectrum Retirement Communities Adds Senior-Level Resident Risk Management, Safety and Preparedness Leader, James Robinson
10/15/2019
Spectrum Retirement Communities, LLC, has added James Robinson to the clinical leadership team.
-
Surescripts Approved as Alternative Test Method for EHRs to Achieve ONC Health IT Certification for E-Prescribing and Ambulatory Medication History Services
10/15/2019
The Office of the National Coordinator for Health IT (ONC) has named Surescripts as an ONC Program Partner for Electronic Prescribing (45 C.F.R. § 170.315(b)(3)) and approved Surescripts as an alternative test method to the ONC-Authorized Testing Laboratory (ONC-ATL).
-
Ligand Appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors
10/15/2019
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (“Ligand” or “the Company”) announces the appointment of Sarah Boyce to the Company's Board of Directors, effective today. Ms. Boyce currently serves as President and CEO of Avidity Biosciences, Inc., a privately held biotechnology company pioneering the use of antibody-oligonucleotide conjugates (AOC™) to treat rare muscle disorders and other serious diseases.
-
Johnson & Johnson Reports 2019 Third-Quarter Results
10/15/2019
Johnson & Johnson announced results for third-quarter 2019.
-
Manatt Health Releases 50-State Survey on 340B in State Medicaid Programs
10/15/2019
First-of-its-kind survey brings clarity to interplay between the Medicaid and 340B programs through comprehensive state analysis
-
Numab Appoints Daniel Vasella to Board of Directors
10/15/2019
Numab Therapeutics AG today announced that effective October 1 it has appointed former Novartis CEO and Chairman Dr. Daniel Vasella to its Board of Directors.
-
HealthVerity and LiveRamp Develop Privacy-Centric Linkage between Patient Healthcare Data and Digital Behavior
10/15/2019
Today at RampUp Chicago, HealthVerity, the trusted foundation for the rapid creation, exchange and management of healthcare and consumer data, and LiveRamp® (NYSE: RAMP) the trusted platform that makes data accessible and meaningful, announced a partnership that will enable the connection of digital behavior with healthcare data in a privacy-centric, HIPAA-compliant manner.
-
Can-Fite Completes Patient Enrollment in Phase II NASH Study of Namodenoson™
10/15/2019
Can-Fite BioPharma Ltd. announced it has completed patient enrollment in its Phase II study of Namodenoson in the treatment of NAFLD/NASH.
-
Co-Diagnostics Expands Vector Control Marketing Nationwide
10/15/2019
Vector Smart™ products being presented at 6 vector control conferences in October to prepare for 2020 mosquito season